Modulation of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors in a human osteoclast model in vitro

Bone Marrow Stroma Confers Resistance to Apo2 Ligand/TRAIL in Multiple Myeloma in Part by Regulating c-FLIP

(2014) L. E. Perez et al.   JOURNAL OF IMMUNOLOGY

TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways

(2011) Muzaffer Cicek et al.   PLoS One

TGF-β in cancer and bone: Implications for treatment of bone metastases

(2010) Patricia Juárez et al.   BONE

PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors and potentiates TRAIL-mediated apoptosis in multiple myeloma cells

(2010) E N Maginn et al.   BRITISH JOURNAL OF CANCER

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis

(2010) Pamela M. Holland et al.   CANCER BIOLOGY & THERAPY

Transforming Growth Factor-β Coordinately Induces Suppressor of Cytokine Signaling 3 and Leukemia Inhibitory Factor to Suppress Osteoclast Apoptosis

(2010) Ming Ruan et al.   ENDOCRINOLOGY

Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

(2010) A.M. Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathway

(2010) Masanobu Tsubaki et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation

(2010) K Mizrahi et al.   LEUKEMIA

New insights into apoptosis signaling by Apo2L/TRAIL

(2010) F Gonzalvez et al.   ONCOGENE

Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma

(2009) Lia E. Perez et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Life and death by death receptors

(2009) Maria Eugenia Guicciardi et al.   FASEB JOURNAL

Transforming Growth Factor-β1 (TGF-β1) Induces Human Osteoclast Apoptosis by Up-regulating Bim

(2009) Nicolas Houde et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The p62 P392L Mutation Linked to Paget’s Disease Induces Activation of Human Osteoclasts

(2009) Estelle Chamoux et al.   MOLECULAR ENDOCRINOLOGY

High-throughput quantification of splicing isoforms

(2009) J.-P. Brosseau et al.   RNA

OPG Is Regulated by  -Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer

(2008) E. N. De Toni et al.   CLINICAL CANCER RESEARCH

Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway

(2008) Estelle Chamoux et al.   JOURNAL OF CELLULAR PHYSIOLOGY

TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5

(2008) Y. Zhang et al.   MOLECULAR CANCER RESEARCH